ALVOAlvotech

$5.79-27% 1Y

Is the price fair?

What ALVO's price assumes

Alvotech trades at 57.9× earnings against 19.7× for the median Drug Manufacturers - Specialty & Generic name, more expensive than its own group.

57.9

Trailing P/E · Drug Manufacturers - Specialty & Generic median 19.7 · 2.94× the median: the market pays up for this one

Details›
Healthcare median P/E509 names
26.2
Drug Manufacturers - Specialty & Generic median P/E45 names
19.7
Market capitalisation
$1.18B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.